• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Profile of specific antibodies to SARS-CoV-2: The first report.

作者信息

Xiao Ai Tang, Gao Chun, Zhang Sheng

机构信息

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.

Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.

出版信息

J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.012. Epub 2020 Mar 21.

DOI:10.1016/j.jinf.2020.03.012
PMID:32209385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7118534/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/7118534/07b068136d27/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/7118534/07b068136d27/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/7118534/07b068136d27/gr1_lrg.jpg

相似文献

1
Profile of specific antibodies to SARS-CoV-2: The first report.新型冠状病毒2019（SARS-CoV-2）特异性抗体概况：首次报告
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.012. Epub 2020 Mar 21.
2
Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?呼吸道标本中SARS-CoV、MERS-CoV和SARS-CoV-2的病毒载量：我们了解到了什么？
Travel Med Infect Dis. 2020 Mar-Apr;34:101629. doi: 10.1016/j.tmaid.2020.101629. Epub 2020 Mar 13.
3
SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression.痰液中的新冠病毒载量与新冠病情进展风险相关。
Crit Care. 2020 Apr 23;24(1):170. doi: 10.1186/s13054-020-02893-8.
4
Re: Profile of specific antibodies to SARS-CoV-2: The first report.关于：新型冠状病毒2019（SARS-CoV-2）特异性抗体的概况：首次报告。
J Infect. 2020 Jul;81(1):e80-e81. doi: 10.1016/j.jinf.2020.03.052. Epub 2020 Apr 10.
5
SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients.重症患者临床样本中的新冠病毒载量
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1435-1438. doi: 10.1164/rccm.202003-0572LE.
6
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).无症状冠状病毒感染：中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2（新型冠状病毒肺炎）
Travel Med Infect Dis. 2020 May-Jun;35:101608. doi: 10.1016/j.tmaid.2020.101608. Epub 2020 Feb 27.
7
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.轻度新冠患者体内抗新冠病毒抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1694-1695. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
8
SARS-CoV-2: virus dynamics and host response.严重急性呼吸综合征冠状病毒2：病毒动力学与宿主反应
Lancet Infect Dis. 2020 May;20(5):515-516. doi: 10.1016/S1473-3099(20)30235-8. Epub 2020 Mar 23.
9
The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体在冠状病毒病（COVID-19）中的作用：多数情况下促进康复，有时也会造成损害。
Respirology. 2020 Jul;25(7):680-682. doi: 10.1111/resp.13852. Epub 2020 May 20.
10
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.轻度新冠肺炎中抗SARS-CoV-2抗体的丧失。回复。
N Engl J Med. 2020 Oct 22;383(17):1697-1698. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.

引用本文的文献

1
Anti-SARS-CoV-2 Antibody Response Among Spectators of Amir Cup 2020 With a History of Recovery From COVID-19 in Qatar: A Historic Cohort Study.卡塔尔2020年阿米尔杯有新冠病毒病康复史观众的抗严重急性呼吸综合征冠状病毒2抗体反应：一项历史性队列研究。
Cureus. 2024 Feb 18;16(2):e54406. doi: 10.7759/cureus.54406. eCollection 2024 Feb.
2
A Correlation Study to Comprehend the SAR-CoV-2 Viral Load, Antiviral Antibody Titer, and Severity of COVID-19 Symptoms Post-infection Amongst the Vaccinated Population in Kamrup District of As sam, Northeast India.一项相关性研究旨在理解在印度东北部阿萨姆邦卡姆鲁普区接种疫苗人群中的 SARS-CoV-2 病毒载量、抗病毒抗体滴度以及感染后 COVID-19 症状的严重程度之间的关系。
Endocr Metab Immune Disord Drug Targets. 2024;24(12):1414-1421. doi: 10.2174/0118715303281124231213110004.
3

本文引用的文献

1
Viral load of SARS-CoV-2 in clinical samples.临床样本中新型冠状病毒2的病毒载量
Lancet Infect Dis. 2020 Apr;20(4):411-412. doi: 10.1016/S1473-3099(20)30113-4. Epub 2020 Feb 24.
2
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
3
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.
Comparative Analysis of Antimicrobial Antibodies between Mild and Severe COVID-19.轻症与重症 COVID-19 患者的抗菌抗体比较分析。
Microbiol Spectr. 2023 Aug 17;11(4):e0469022. doi: 10.1128/spectrum.04690-22. Epub 2023 Jun 6.
4
Diagnostic performance of four lateral flow immunoassays for COVID-19 antibodies in Peruvian population.四种侧向流动免疫测定法检测秘鲁人群中新冠病毒抗体的诊断性能
PLOS Glob Public Health. 2023 Jun 2;3(6):e0001555. doi: 10.1371/journal.pgph.0001555. eCollection 2023.
5
Clinical application of SARS-CoV-2 antibody detection and monoclonal antibody therapies against COVID-19.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体检测及抗2019冠状病毒病单克隆抗体疗法的临床应用
World J Clin Cases. 2023 Apr 6;11(10):2168-2180. doi: 10.12998/wjcc.v11.i10.2168.
6
A false positive serology test of SARS‑CoV‑2 in a patient with Waldenström's macroglobulinemia: A case report.华氏巨球蛋白血症患者出现严重急性呼吸综合征冠状病毒2（SARS-CoV-2）血清学假阳性检测结果：一例报告
Exp Ther Med. 2023 Mar 21;25(5):200. doi: 10.3892/etm.2023.11899. eCollection 2023 May.
7
The COVID-19 pandemic in sub-Saharan Africa: The significance of presumed immune sufficiency.撒哈拉以南非洲的新冠疫情：假定免疫充足的意义。
Afr J Lab Med. 2023 Jan 30;12(1):1964. doi: 10.4102/ajlm.v12i1.1964. eCollection 2023.
8
SARS-CoV-2 Testing Strategies in the Diagnosis and Management of COVID-19 Patients in Low-Income Countries: A Scoping Review.低收入国家 COVID-19 患者诊断和管理中的 SARS-CoV-2 检测策略：范围综述。
Mol Diagn Ther. 2023 May;27(3):303-320. doi: 10.1007/s40291-022-00637-8. Epub 2023 Jan 27.
9
Epidemiological and clinical characteristics of vaccinated COVID-19 patients: A meta-analysis and systematic review.接种 COVID-19 疫苗患者的流行病学和临床特征：荟萃分析和系统评价。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221141802. doi: 10.1177/03946320221141802.
10
Biomarkers of sequela in adult patients convalescing from COVID-19.COVID-19康复期成年患者后遗症的生物标志物
Adv Biomark Sci Technol. 2022;4:36-53. doi: 10.1016/j.abst.2022.10.001. Epub 2022 Nov 9.
感染患者上呼吸道标本中的新型冠状病毒2型病毒载量
N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.
4
Emergence of a novel coronavirus causing respiratory illness from Wuhan, China.一种源自中国武汉、引发呼吸道疾病的新型冠状病毒出现了。
J Infect. 2020 Mar;80(3):350-371. doi: 10.1016/j.jinf.2020.01.014. Epub 2020 Jan 28.
5
Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance.SARS患者抗SARS冠状病毒抗体的动态变化及其临床意义
Respirology. 2006 Jan;11(1):49-53. doi: 10.1111/j.1440-1843.2006.00783.x.